0
0
0
Hatch-Waxman Improvement Act of 2022
12/29/2022, 5:33 PM
Congressional Summary of S 4378
Hatch-Waxman Improvement Act of 2022
This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).
Read the Full Bill
Current Status of Bill S 4378
Bill S 4378 is currently in the status of Bill Introduced since June 13, 2022. Bill S 4378 was introduced during Congress 117 and was introduced to the Senate on June 13, 2022. Bill S 4378's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 13, 2022
Bipartisan Support of Bill S 4378
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 4378
Primary Policy Focus
HealthAlternate Title(s) of Bill S 4378
Hatch-Waxman Improvement Act of 2022
Hatch-Waxman Improvement Act of 2022
A bill to reauthorize a provision of the Federal Food, Drug, and Cosmetic Act pertaining to drugs containing single enantiomers.
Comments
Sponsors and Cosponsors of S 4378
Latest Bills
Recover COVID Unemployment Fraud in Banks Act
Bill HR 8873May 30, 2026
No Aid for Ghost Students Act of 2026
Bill HR 7892May 30, 2026
Preventing Waste, Fraud, and Abuse in TANF Act
Bill HR 8872May 30, 2026
Student Aid Fraud Oversight and Accountability Act of 2026
Bill HR 7891May 30, 2026
Prove It Act
Bill HR 1163May 30, 2026
CONNECT Act
Bill HR 7995May 30, 2026
Foster Youth Workforce Opportunity Act
Bill HR 7343May 30, 2026
Foster Youth Postsecondary Education Access and Success Act
Bill HR 7463May 30, 2026
Fresh Starts for Foster Youth Act
Bill HR 7529May 30, 2026
Support for Expectant and Parenting Foster Youth Act
Bill HR 7655May 30, 2026
FDASLA Act of 2022
Bill S 4348December 29, 2022